• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于可穿戴人工胰腺的嵌入式模型预测控制

Embedded Model Predictive Control for a Wearable Artificial Pancreas.

作者信息

Chakrabarty Ankush, Healey Elizabeth, Shi Dawei, Zavitsanou Stamatina, Doyle Francis J, Dassau Eyal

机构信息

Control and Dynamical Systems Group, Mitsubishi Electric Research Laboratories, Cambridge, MA, USA.

Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA.

出版信息

IEEE Trans Control Syst Technol. 2020 Nov;28(6):2600-2607. doi: 10.1109/tcst.2019.2939122. Epub 2019 Sep 18.

DOI:10.1109/tcst.2019.2939122
PMID:33762804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7983018/
Abstract

While artificial pancreas (AP) systems are expected to improve the quality of life among people with type 1 diabetes mellitus (T1DM), the design of convenient systems that optimize the user experience, especially for those with active lifestyles, such as children and adolescents, still remains an open research question. In this work, we introduce an embeddable design and implementation of model predictive control (MPC) of AP systems for people with T1DM that significantly reduces the weight and on-body footprint of the AP system. The embeddable controller is based on a zone MPC that has been evaluated in multiple clinical studies. The proposed embedded zone MPC features a simpler design of the periodic safe zone in the cost function and the utilization of state-of-the-art alternating minimization algorithms for solving the convex programming problems inherent to MPC with linear models subject to convex constraints. Off-line closed-loop data generated by the FDA-accepted UVA/Padova simulator is used to select an optimization algorithm and corresponding tuning parameters. Through hardware-in-the-loop results on a limited-resource Arduino Zero (Feather M0) platform, we demonstrate the potential of the proposed embedded MPC. In spite of resource limitations, our embedded zone MPC manages to achieve comparable performance of that of the full-version zone MPC implemented in a 64-bit desktop for scenarios with/without meal-disturbance compensations. Metrics for performance comparison included median percent time in the euglycemic ([70, 180] mg/dL range) of 84.3% vs. 83.1% for announced meals, with an equivalence test yielding = 0.0013 and 66.2% vs. 66.0% for unannounced meals with = 0.0028.

摘要

虽然人工胰腺(AP)系统有望改善1型糖尿病(T1DM)患者的生活质量,但设计方便的系统以优化用户体验,特别是对于儿童和青少年等生活方式活跃的人群,仍然是一个开放的研究问题。在这项工作中,我们介绍了一种可嵌入的设计和实现,用于T1DM患者的AP系统的模型预测控制(MPC),该设计显著降低了AP系统的重量和体表占用面积。可嵌入控制器基于一种区域MPC,该区域MPC已在多项临床研究中得到评估。所提出的嵌入式区域MPC在成本函数中具有更简单的周期性安全区域设计,并利用了先进的交替最小化算法来解决MPC中固有的凸规划问题,该问题具有受凸约束的线性模型。由FDA认可的UVA/帕多瓦模拟器生成的离线闭环数据用于选择优化算法和相应的调整参数。通过在资源有限的Arduino Zero(Feather M0)平台上进行硬件在环测试,我们展示了所提出的嵌入式MPC的潜力。尽管存在资源限制,但对于有/无进餐干扰补偿的场景,我们的嵌入式区域MPC仍能实现与在64位桌面计算机上实现的完整版区域MPC相当的性能。性能比较指标包括:对于已宣布的进餐,血糖正常([70, 180]mg/dL范围)的中位时间百分比为84.3%对83.1%,等效性检验得出p = 0.0013;对于未宣布的进餐,血糖正常的中位时间百分比为66.2%对66.0%,p = 0.0028。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/7cfd0cfcbd6c/nihms-1636186-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/26e195807f4a/nihms-1636186-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/942ea278ada1/nihms-1636186-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/5a0f731ce30a/nihms-1636186-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/dcc483bc6006/nihms-1636186-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/00b139d235c2/nihms-1636186-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/7cfd0cfcbd6c/nihms-1636186-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/26e195807f4a/nihms-1636186-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/942ea278ada1/nihms-1636186-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/5a0f731ce30a/nihms-1636186-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/dcc483bc6006/nihms-1636186-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/00b139d235c2/nihms-1636186-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e8c/7983018/7cfd0cfcbd6c/nihms-1636186-f0006.jpg

相似文献

1
Embedded Model Predictive Control for a Wearable Artificial Pancreas.用于可穿戴人工胰腺的嵌入式模型预测控制
IEEE Trans Control Syst Technol. 2020 Nov;28(6):2600-2607. doi: 10.1109/tcst.2019.2939122. Epub 2019 Sep 18.
2
Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.区域模型预测控制:一种将高血糖和低血糖事件降至最低的策略。
J Diabetes Sci Technol. 2010 Jul 1;4(4):961-75. doi: 10.1177/193229681000400428.
3
Event-Triggered Model Predictive Control for Embedded Artificial Pancreas Systems.基于事件触发的嵌入式人工胰腺系统模型预测控制
IEEE Trans Biomed Eng. 2018 Mar;65(3):575-586. doi: 10.1109/TBME.2017.2707344. Epub 2017 May 23.
4
Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties.基于葡萄糖和速度相关控制罚函数的人工胰腺自适应区域模型预测控制。
IEEE Trans Biomed Eng. 2019 Apr;66(4):1045-1054. doi: 10.1109/TBME.2018.2866392. Epub 2018 Aug 21.
5
Zone-MPC Automated Insulin Delivery Algorithm Tuned for Pregnancy Complicated by Type 1 Diabetes.区域-MPC 自动化胰岛素输送算法针对 1 型糖尿病合并妊娠进行调整。
Front Endocrinol (Lausanne). 2022 Mar 22;12:768639. doi: 10.3389/fendo.2021.768639. eCollection 2021.
6
Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.高级混合人工胰腺系统提高了对未通知用餐的反应能力-与当前可用系统的模拟比较。
Comput Methods Programs Biomed. 2021 Nov;211:106401. doi: 10.1016/j.cmpb.2021.106401. Epub 2021 Sep 13.
7
Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.人工胰腺个性化模型预测控制(MPC)和比例积分微分(PID)控制算法的随机交叉比较
Diabetes Care. 2016 Jul;39(7):1135-42. doi: 10.2337/dc15-2344. Epub 2016 Jun 11.
8
Artificial pancreas: model predictive control design from clinical experience.人工胰腺:基于临床经验的模型预测控制设计
J Diabetes Sci Technol. 2013 Nov 1;7(6):1470-83. doi: 10.1177/193229681300700607.
9
Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems.在多变量人工胰腺系统的自适应模型预测控制中融入先验信息。
J Diabetes Sci Technol. 2022 Jan;16(1):19-28. doi: 10.1177/19322968211059149. Epub 2021 Dec 3.
10
Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.基于内部模型控制的模块,用于消除混合人工胰腺系统中的进餐和运动通知。
Comput Methods Programs Biomed. 2022 Nov;226:107061. doi: 10.1016/j.cmpb.2022.107061. Epub 2022 Aug 8.

引用本文的文献

1
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.自动胰岛素输送系统的研究空白、挑战与机遇
J Diabetes Sci Technol. 2025 Jul;19(4):937-949. doi: 10.1177/19322968251338754. Epub 2025 Jul 1.
2
DEMIGOD: A Low-Cost Microcontroller-Based Closed-Loop System Integrating Nanoengineered Sweat-Based Glucose Monitoring and Controlled Transdermal Nanoemulsion Release of Hypoglycemic Treatment with a Software Application for Noninvasive Personalized Diabetes Care.半人半神:一种基于低成本微控制器的闭环系统,集成了纳米工程化的基于汗液的葡萄糖监测以及用于低血糖治疗的可控透皮纳米乳剂释放,并配有用于无创个性化糖尿病护理的软件应用程序。
Micromachines (Basel). 2024 Jul 6;15(7):887. doi: 10.3390/mi15070887.
3

本文引用的文献

1
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.临床连续血糖监测数据解读目标:时间范围国际共识推荐意见。
Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8.
2
Velocity-weighting & velocity-penalty MPC of an artificial pancreas: Improved safety & performance.人工胰腺的速度加权和速度惩罚模型预测控制:安全性和性能的提升
Automatica (Oxf). 2018 May;91:105-117. doi: 10.1016/j.automatica.2018.01.025. Epub 2018 Mar 20.
3
Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.
Performance Analysis of Different Embedded Systems and Open-Source Optimization Packages Towards an Impulsive MPC Artificial Pancreas.
不同嵌入式系统和开源优化包在冲击式 MPC 人工胰腺中的性能分析。
Front Endocrinol (Lausanne). 2021 Apr 26;12:662348. doi: 10.3389/fendo.2021.662348. eCollection 2021.
输注装置和传感器长期使用期间区域模型预测控制人工胰腺的应用:一项随机交叉对照家庭使用试验。
Diabetes Care. 2017 Aug;40(8):1096-1102. doi: 10.2337/dc17-0500. Epub 2017 Jun 5.
4
Event-Triggered Model Predictive Control for Embedded Artificial Pancreas Systems.基于事件触发的嵌入式人工胰腺系统模型预测控制
IEEE Trans Biomed Eng. 2018 Mar;65(3):575-586. doi: 10.1109/TBME.2017.2707344. Epub 2017 May 23.
5
Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.基于模型预测控制的全自动人工胰腺中,与皮下胰岛素输注相比,腹腔内胰岛素输注可改善 1 型糖尿病患者的血糖控制:一项初步研究。
Diabetes Obes Metab. 2017 Dec;19(12):1698-1705. doi: 10.1111/dom.12999. Epub 2017 Jul 6.
6
Metrics for glycaemic control - from HbA to continuous glucose monitoring.血糖控制的指标——从 HbA 到连续血糖监测。
Nat Rev Endocrinol. 2017 Jul;13(7):425-436. doi: 10.1038/nrendo.2017.3. Epub 2017 Mar 17.
7
Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes.用于人工胰腺治疗1型糖尿病门诊就绪安全性的具有不对称成本的周期性区域-MPC
Automatica (Oxf). 2016 Sep;71:237-246. doi: 10.1016/j.automatica.2016.04.015. Epub 2016 Jun 1.
8
Exploration of the Performance of a Hybrid Closed Loop Insulin Delivery Algorithm That Includes Insulin Delivery Limits Designed to Protect Against Hypoglycemia.探索一种混合闭环胰岛素给药算法的性能,该算法包括旨在预防低血糖的胰岛素给药限制。
J Diabetes Sci Technol. 2017 Jan;11(1):68-73. doi: 10.1177/1932296816668876. Epub 2016 Sep 25.
9
Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.人工胰腺个性化模型预测控制(MPC)和比例积分微分(PID)控制算法的随机交叉比较
Diabetes Care. 2016 Jul;39(7):1135-42. doi: 10.2337/dc15-2344. Epub 2016 Jun 11.
10
Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe.5 至 9 岁儿童随机夏令营交叉试验:门诊使用可穿戴式人工胰腺是可行且安全的。
Diabetes Care. 2016 Jul;39(7):1180-5. doi: 10.2337/dc15-2815. Epub 2016 May 10.